Larvol Delta - CINC424C2416-Study-of-Efficacy-and-Safety-of-Ruxolitinib-in-Patients-With-Grade-II-to-IV-Steroidrefractory-Acute-Graft-vs-Host-Disease

Jakafi (ruxolitinib) - Incyte

http://clinicaltrials.gov/ct2/show/NCT06462469

Aug 28, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next